The Claim
Neuronal overexpression of A2A receptors in APP/PS1 mice increases phosphorylated tau at neuritic plaques without altering overall amyloid plaque load or total Aβ levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice genetically engineered to develop Alzheimer’s-like brain changes, increasing A2A receptor activity in neurons leads to more phosphorylated tau protein accumulating around amyloid plaques, while the amount of amyloid plaques and total Aβ protein remains unchanged.
See the scientific wording
In APP/PS1 mice, neuronal overexpression of A2A receptors increases phosphorylated tau at neuritic plaques without altering overall amyloid plaque load or total Aβ levels, suggesting a selective interaction between A2AR and tau pathology in the context of amyloidosis.
When a specific receptor in brain cells is overactive, it disrupts the cell's energy production and triggers inflammation around brain plaques. This creates a local environment that causes abnormal tau protein to become chemically modified and stick to the plaques, without changing the amount of plaque or other related proteins.
What the research says
1 studyStudy: Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice
In mice with Alzheimer’s-like brain plaques, turning up a specific brain receptor (A2A) made more abnormal tau protein build up around the plaques, even though the plaques themselves didn’t get bigger. This suggests the receptor specifically makes tau damage worse.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.